From: Peter Thiel Sent: Sunday, September 14, 2014 4:15 PM To: Jeffrey Epstein ([email protected]) Subject: FW: Reply to Benzo study Quick feedback from my on-staff health expert... =/o:p> Last ni=ht was a lot of fun, as always! =span style&color:#1F497D1> <= class=MsoNormal>From: Jason Camm Sent: Sunday, September 14, 2=14 8:44 AM To: Peter Thiel Subject: Reply to Benzo stu=y Yes, I saw this a few days ago. Initial thoughts,=Benzodiazapines act on similar receptors to GHB. Whilst they are both CNS =epressants, Benzo's actually reduce the amount of stage 3 and 4 slee= (deep sleep associated with growth hormone release and memory consolidati=n) to almost negligible levels. GHB, as we have discussed before, is actua=ly a potent initiator of stage 3 and 4 sleep. Whilst I think the associ=tion does deserve further study, there are a few explanations that can be =onsidered from this paper: 1.&n=sp; A true associati=n that reflects Benzo use in the early stages of AD 2. <=[endif)>Benzo's may cause minor brain damage additive to AD 3. =/span>A direct relationship between Benzo and the AD dise=se process 4. =nbsp; This could all be a false positi=e/ statistical fluke ap> A few poi=ts of note: EFTA_R1_01409225 EFTA02387645